Protein S multimers and monomers each have direct anticoagulant activity

J Thromb Haemost. 2006 Feb;4(2):385-91. doi: 10.1111/j.1538-7836.2006.01743.x.

Abstract

Background and objectives: Plasma protein S (PS) is an essential anticoagulant that has activated protein C-independent, direct anticoagulant activity (PS-direct). It was reported that monomeric purified PS has poor PS-direct and that a subpopulation of multimeric purified PS has high PS-direct and high affinity for phospholipids. We independently examined the relative PS-direct and affinity for phospholipids of monomeric and multimeric PS and we obtained contrasting results.

Methods and results: Unpurified recombinant protein S (rPS) was monomeric and had PS-direct potency similar to that of both PS in plasma and multimeric affinity-purified PS, as measured in plasma assays for PS-direct and in thrombin-generation assays. Multimers of unpurified rPS were not induced by ethylenediaminetetraacetic acid (EDTA), pH 2.5, NaSCN, or barium adsorption/elution. Multimers were induced by chromatography in the presence of EDTA and thus may be concentration-dependent. In contrast to a different report, monomers, dimers, trimers, and higher-order PS forms were clearly separated in sedimentation velocity experiments and multimers were not dissociated by adding Ca(2+). Active plasma-derived and recombinant immunoaffinity-purified PS were fractionated into monomers and multimers. On a mass basis, monomers and multimers had similar specific PS-direct and ability to compete with prothrombinase components (factors Xa/Va) for limiting phospholipids. FXa ligand blotted to both monomers and multimers.

Conclusions: Plasma PS-direct is similar to that of affinity-purified PS and unpurified rPS. Under our conditions, monomeric and multimeric PS have similar PS-direct and ability to compete for phospholipids. Discordant earlier findings are likely due to loss of PS-direct during conventional purification procedures.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / chemistry*
  • Anticoagulants / isolation & purification
  • Anticoagulants / metabolism
  • Anticoagulants / pharmacology*
  • Binding, Competitive
  • Complement C4b-Binding Protein
  • Dimerization
  • Factor Xa / metabolism
  • Histocompatibility Antigens / pharmacology
  • Humans
  • In Vitro Techniques
  • Ligands
  • Phospholipids / metabolism
  • Protein S / chemistry*
  • Protein S / isolation & purification
  • Protein S / metabolism
  • Protein S / pharmacology*
  • Protein Structure, Quaternary
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / pharmacology
  • Ultracentrifugation

Substances

  • Anticoagulants
  • C4BPA protein, human
  • Complement C4b-Binding Protein
  • Histocompatibility Antigens
  • Ligands
  • Phospholipids
  • Protein S
  • Recombinant Proteins
  • Factor Xa